II TİP ŞƏKƏRLİ DİABETLİ XƏSTƏLƏRDƏ DİABETİK MAKULA ÖDEMİ İLƏ MÜŞAYİƏT OLUNAN DİABETİK RETİNOPATİYANIN MÜALİCƏSİNİN UZAQ NƏTİCƏLƏRİ

Xülasə

SUMMARY

Aim – the study aimed to value the long-term results of laser coagulation and combined treatment of diabetic macular edema (DME) on the base of data obtained by FFA and OCT.

Material and methods
The retrospective analysis medical cards of 167 2nd type DM patients (223) with DME who had applied to the of diabetes mellitus complications and vitreal surgery department of the National Centre Ophthalmology named after acad. Z.Aliyeva during 2008-2013 was performed. This analysis united the results of combined treatment by methods of lasercoaculation or intravitreal injection (ranibizumab, bevacizumab, afibercept and triamcinolone). According to the generally accepted classifcation of DME and on the base of the FFA and OCT data, all patients were divided into 3 main groups. I group – 81 patient (115 eyes) with diabetic rethinopathy accompanied by focal edema who were subjected to the treatment focal l/k+PRP. II group – 50 patient (60 eyes) with DR accompanied by the mixed DME. Taking into account the difference of treatment methods, this group was divided in 2 subgroups: II-A – 18 patients (20 eyes) with focal grid l/ k+intravitreal injection+ PRP treatment; II-B – 32 patients (40 eyes) with focal-grid l/k+PRP. III group – 36 patients (48 eyes) with DR accompanied by the diffuse cystic edema. This group also was subdivided into 2 subgroups: III-A – 20 patients (26 eyes) with i/v + grid l/k + PRP treatment. III-B – 16 patients (22 eyes) with i\v injection +PRP.

Conclusion
In diabetic retinopathy accompanied by the focal diabetic maculopathy, according to the anatomical and functional data, the single and irreplaceable treatment method of macular edema is the focal l/c. In DR with mixed DME on the base of the more stable anatomical and functional indices, the effective method of treatment may be combined treatment. In diffuse macular edema the combined treatment is the more effective, the evidence of which is the decrease in the number of intravitreal injections.